SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
May 23 2013 | VICL | Vical Inc | Morrow George J | Director | 5,953 | Purchase at $0.01 | $60 | |
May 16 2013 | ALGN | Align Technology Inc | Morrow George J | Director | 7,700 | Converted deriv at $0.00 | $0 | |
Oct 15 2012 | VICL | Vical Inc | Morrow George J | Director | 6,394 | Purchase at $0.01 | $64 | |
Jul 30 2012 | HGSI | Human Genome Sciences Inc | Morrow George J | Director | 4,166 | Sale to issuer at $14.25 | $59,366 | |
Jul 30 2012 | HGSI | Human Genome Sciences Inc | Morrow George J | Director | 10,834 | Tender at $14.25 | $154,385 | |
May 21 2012 | ALGN | Align Technology Inc | Morrow George J | Director | 3,000 | Converted deriv at $0.00 | $0 | |
May 17 2012 | HGSI | Human Genome Sciences Inc | Morrow George J | Director | 2,500 | Grant at $0.00 | $0 | |
Aug 5 2011 | HGSI | Human Genome Sciences Inc | Morrow George J | Director | 10,000 | Purchase at $15.79 | $157,900 | |
May 19 2011 | ALGN | Align Technology Inc | Morrow George J | Director | 3,000 | Converted deriv at $0.00 | $0 | |
May 12 2011 | HGSI | Human Genome Sciences Inc | Morrow George J | Director | 2,500 | Grant at $0.00 | $0 | |
May 20 2010 | ALGN | Align Technology Inc | Morrow George J | Director | 3,000 | Converted deriv at $0.00 | $0 | |
MApr 28 2010 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 2,802 | Option payment at $58.01 | $162,544 | |
Apr 26 2010 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 12,000 | Grant at $0.00 | $0 | |
Mar 12 2010 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 12,324 | Grant at $0.00 | $0 | |
Mar 12 2010 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 5,753 | Option payment at $57.49 | $330,740 | |
Jun 9 2009 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 21,000 | Option exercise at $42.13 | $884,730 | |
MJun 9 2009 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 21,000 | Sale at $51.07 | $1,072,564 | |
May 15 2009 | ALGN | Align Technology Inc | Morrow George J | Director | 3,000 | Converted deriv at $0.00 | $0 | |
May 7 2009 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 19,207 | Grant at $0.00 | $0 | |
May 8 2009 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 8,788 | Option payment at $47.63 | $418,572 | |
Apr 29 2009 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 1,373 | Option payment at $50.44 | $69,254 | |
Apr 28 2009 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 12,000 | Grant at $0.00 | $0 | |
Oct 24 2008 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 57,394 | Option exercise at $38.36 | $2,201,634 | |
Oct 24 2008 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 57,394 | Sale at $54.48 | $3,126,641 | |
May 15 2008 | ALGN | Align Technology Inc | Morrow George J | Director | 3,000 | Converted deriv at $0.00 | $0 | |
MMay 15 2008 | ALGN | Align Technology Inc | Morrow George J | Director | 5,000 | Purchase at $12.63 | $63,139 | |
May 12 2008 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 26,891 | Option payment at $41.86 | $1,125,657 | |
May 7 2008 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 60,658 | Grant at $0.00 | $0 | |
Apr 29 2008 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 12,000 | Grant at $0.00 | $0 | |
Dec 10 2007 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 2,609 | Option exercise at $38.36 | $100,081 | |
Dec 7 2007 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 2,025 | Purchase at $69.97 | $141,719 | |
May 11 2007 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 27,401 | Option payment at $54.25 | $1,486,504 | |
May 8 2007 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 62,698 | Grant at $0.00 | $0 | |
MJul 25 2005 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 303,335 | Option exercise at $58.30 | $17,684,522 | |
MJul 25 2005 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 303,335 | Sale at $81.11 | $24,604,492 | |
Nov 23 2004 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 59,998 | Option exercise at $38.36 | $2,301,523 | |
MNov 23 2004 | AMGN | Amgen Inc | Morrow George J | Exe VP, Global Commercial Ops | 59,998 | Sale at $59.59 | $3,575,131 |